Cargando…

Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study

Hypertension is described by the world health organization (WHO) as a serious medical problem that significantly affects the heart, brain and kidneys. It is a major cause of premature death worldwide. The present study aims to quantify the combination of captopril (CPL), hydrochlorothiazide (HCZ) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagieb, Hend M., Abdelwahab, Nada S., Abdelrahman, Maha M., Zaazaa, Hala E., Ghoniem, Nermine S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630503/
https://www.ncbi.nlm.nih.gov/pubmed/37935740
http://dx.doi.org/10.1038/s41598-023-46636-5
_version_ 1785132163410165760
author Nagieb, Hend M.
Abdelwahab, Nada S.
Abdelrahman, Maha M.
Zaazaa, Hala E.
Ghoniem, Nermine S.
author_facet Nagieb, Hend M.
Abdelwahab, Nada S.
Abdelrahman, Maha M.
Zaazaa, Hala E.
Ghoniem, Nermine S.
author_sort Nagieb, Hend M.
collection PubMed
description Hypertension is described by the world health organization (WHO) as a serious medical problem that significantly affects the heart, brain and kidneys. It is a major cause of premature death worldwide. The present study aims to quantify the combination of captopril (CPL), hydrochlorothiazide (HCZ) and their harmful impurities; captopril disulphide (CDS), chlorothiaizde (CTZ) and salamide (SMD). In-silico study was conducted for estimation of pharmacokinetic parameters (ADMET) as well as toxicity profile of the proposed impurities. The results showed that the three impurities under investigation had poor permeability to CNS and cannot pass the blood–brain barrier (BBB), reducing the likelihood of causing side effects in the brain. On the other hand, all studied impurities were found to be hepatotoxic. In consequence, a highly sensitive and green ultra-performance liquid chromatography- tandem mass spectrometric (UPLC/MS/MS) method was developed and validated for separation of the cited drugs in the presence of their harmful impurities; methanol and 0.1% formic acid (90:10, v/v) mixture was used as a mobile phase, eluted at a constant flow rate of 0.7 mL/min at room temperature. Detection was adopted using a tandem mass spectrometer in a positive mode only for CPL and negative mode for HCZ, CDS, CTZ and SMD. Separation was performed within 1 min. Calibration graphs were found to be linear in the ranges of (50.0–500.0 ng mL(−1)), (20.0–500.0 ng mL(−1)), (10.0–250.0 ng mL(−1)), (5.0–250.0 ng mL(−1)) and (20.0–400.0 ng mL(−1)) corresponding to CPL, HCZ, CDS, CTZ and SMD, respectively. Additionally, comparative study of greenness profile was established for the proposed and reported methods using five green metric tools. The proposed method was found to be greener than the reported HPLC method. The developed (UPLC/MS/MS) method was validated according to (ICH) guidelines and it was found to has greater sensitivity, shorter analysis time and lower environmental impact compared to the reported methods.
format Online
Article
Text
id pubmed-10630503
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106305032023-11-07 Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study Nagieb, Hend M. Abdelwahab, Nada S. Abdelrahman, Maha M. Zaazaa, Hala E. Ghoniem, Nermine S. Sci Rep Article Hypertension is described by the world health organization (WHO) as a serious medical problem that significantly affects the heart, brain and kidneys. It is a major cause of premature death worldwide. The present study aims to quantify the combination of captopril (CPL), hydrochlorothiazide (HCZ) and their harmful impurities; captopril disulphide (CDS), chlorothiaizde (CTZ) and salamide (SMD). In-silico study was conducted for estimation of pharmacokinetic parameters (ADMET) as well as toxicity profile of the proposed impurities. The results showed that the three impurities under investigation had poor permeability to CNS and cannot pass the blood–brain barrier (BBB), reducing the likelihood of causing side effects in the brain. On the other hand, all studied impurities were found to be hepatotoxic. In consequence, a highly sensitive and green ultra-performance liquid chromatography- tandem mass spectrometric (UPLC/MS/MS) method was developed and validated for separation of the cited drugs in the presence of their harmful impurities; methanol and 0.1% formic acid (90:10, v/v) mixture was used as a mobile phase, eluted at a constant flow rate of 0.7 mL/min at room temperature. Detection was adopted using a tandem mass spectrometer in a positive mode only for CPL and negative mode for HCZ, CDS, CTZ and SMD. Separation was performed within 1 min. Calibration graphs were found to be linear in the ranges of (50.0–500.0 ng mL(−1)), (20.0–500.0 ng mL(−1)), (10.0–250.0 ng mL(−1)), (5.0–250.0 ng mL(−1)) and (20.0–400.0 ng mL(−1)) corresponding to CPL, HCZ, CDS, CTZ and SMD, respectively. Additionally, comparative study of greenness profile was established for the proposed and reported methods using five green metric tools. The proposed method was found to be greener than the reported HPLC method. The developed (UPLC/MS/MS) method was validated according to (ICH) guidelines and it was found to has greater sensitivity, shorter analysis time and lower environmental impact compared to the reported methods. Nature Publishing Group UK 2023-11-07 /pmc/articles/PMC10630503/ /pubmed/37935740 http://dx.doi.org/10.1038/s41598-023-46636-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Nagieb, Hend M.
Abdelwahab, Nada S.
Abdelrahman, Maha M.
Zaazaa, Hala E.
Ghoniem, Nermine S.
Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study
title Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study
title_full Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study
title_fullStr Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study
title_full_unstemmed Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study
title_short Greenness assessment of UPLC/MS/MS method for determination of two antihypertensive agents and their harmful impurities with ADME/TOX profile study
title_sort greenness assessment of uplc/ms/ms method for determination of two antihypertensive agents and their harmful impurities with adme/tox profile study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630503/
https://www.ncbi.nlm.nih.gov/pubmed/37935740
http://dx.doi.org/10.1038/s41598-023-46636-5
work_keys_str_mv AT nagiebhendm greennessassessmentofuplcmsmsmethodfordeterminationoftwoantihypertensiveagentsandtheirharmfulimpuritieswithadmetoxprofilestudy
AT abdelwahabnadas greennessassessmentofuplcmsmsmethodfordeterminationoftwoantihypertensiveagentsandtheirharmfulimpuritieswithadmetoxprofilestudy
AT abdelrahmanmaham greennessassessmentofuplcmsmsmethodfordeterminationoftwoantihypertensiveagentsandtheirharmfulimpuritieswithadmetoxprofilestudy
AT zaazaahalae greennessassessmentofuplcmsmsmethodfordeterminationoftwoantihypertensiveagentsandtheirharmfulimpuritieswithadmetoxprofilestudy
AT ghoniemnermines greennessassessmentofuplcmsmsmethodfordeterminationoftwoantihypertensiveagentsandtheirharmfulimpuritieswithadmetoxprofilestudy